No Arabic abstract
We propose the SH model, a simplified version of the well-known SIR compartmental model of infectious diseases. With optimized parameters and initial conditions, this time-invariant two-parameter two-dimensional model is able to fit COVID-19 hospitalization data over several months with high accuracy (mean absolute percentage error below 15%). Moreover, we observed that, when the model is trained on a suitable two-week period around the hospitalization peak for Belgium, it forecasts the subsequent three-month decrease with mean absolute percentage error below 10%. However, when it is trained in the increase phase, it is less successful at forecasting the subsequent evolution.
Most COVID-19 predictive modeling efforts use statistical or mathematical models to predict national- and state-level COVID-19 cases or deaths in the future. These approaches assume parameters such as reproduction time, test positivity rate, hospitalization rate, and social intervention effectiveness (masking, distancing, and mobility) are constant. However, the one certainty with the COVID-19 pandemic is that these parameters change over time, as well as vary across counties and states. In fact, the rate of spread over region, hospitalization rate, hospital length of stay and mortality rate, the proportion of the population that is susceptible, test positivity rate, and social behaviors can all change significantly over time. Thus, the quantification of uncertainty becomes critical in making meaningful and accurate forecasts of the future. Bayesian approaches are a natural way to fully represent this uncertainty in mathematical models and have become particularly popular in physics and engineering models. The explicit integration time varying parameters and uncertainty quantification into a hierarchical Bayesian forecast model differentiates the Mayo COVID-19 model from other forecasting models. By accounting for all sources of uncertainty in both parameter estimation as well as future trends with a Bayesian approach, the Mayo COVID-19 model accurately forecasts future cases and hospitalizations, as well as the degree of uncertainty. This approach has been remarkably accurate and a linchpin in Mayo Clinics response to managing the COVID-19 pandemic. The model accurately predicted timing and extent of the summer and fall surges at Mayo Clinic sites, allowing hospital leadership to manage resources effectively to provide a successful pandemic response. This model has also proven to be very useful to the state of Minnesota to help guide difficult policy decisions.
Since two people came down a county of north Seattle with positive COVID-19 (coronavirus-19) in 2019, the current total cases in the United States (U.S.) are over 12 million. Predicting the pandemic trend under effective variables is crucial to help find a way to control the epidemic. Based on available literature, we propose a validated Vector Autoregression (VAR) time series model to predict the positive COVID-19 cases. A real data prediction for U.S. is provided based on the U.S. coronavirus data. The key message from our study is that the situation of the pandemic will getting worse if there is no effective control.
The coronavirus disease 2019 (COVID-19) global pandemic has led many countries to impose unprecedented lockdown measures in order to slow down the outbreak. Questions on whether governments have acted promptly enough, and whether lockdown measures can be lifted soon have since been central in public discourse. Data-driven models that predict COVID-19 fatalities under different lockdown policy scenarios are essential for addressing these questions and informing governments on future policy directions. To this end, this paper develops a Bayesian model for predicting the effects of COVID-19 lockdown policies in a global context -- we treat each country as a distinct data point, and exploit variations of policies across countries to learn country-specific policy effects. Our model utilizes a two-layer Gaussian process (GP) prior -- the lower layer uses a compartmental SEIR (Susceptible, Exposed, Infected, Recovered) model as a prior mean function with country-and-policy-specific parameters that capture fatality curves under counterfactual policies within each country, whereas the upper layer is shared across all countries, and learns lower-layer SEIR parameters as a function of a countrys features and its policy indicators. Our model combines the solid mechanistic foundations of SEIR models (Bayesian priors) with the flexible data-driven modeling and gradient-based optimization routines of machine learning (Bayesian posteriors) -- i.e., the entire model is trained end-to-end via stochastic variational inference. We compare the projections of COVID-19 fatalities by our model with other models listed by the Center for Disease Control (CDC), and provide scenario analyses for various lockdown and reopening strategies highlighting their impact on COVID-19 fatalities.
We address the problem of modeling constrained hospital resources in the midst of the COVID-19 pandemic in order to inform decision-makers of future demand and assess the societal value of possible interventions. For broad applicability, we focus on the common yet challenging scenario where patient-level data for a region of interest are not available. Instead, given daily admissions counts, we model aggregated counts of observed resource use, such as the number of patients in the general ward, in the intensive care unit, or on a ventilator. In order to explain how individual patient trajectories produce these counts, we propose an aggregate count explicit-duration hidden Markov model, nicknamed the ACED-HMM, with an interpretable, compact parameterization. We develop an Approximate Bayesian Computation approach that draws samples from the posterior distribution over the models transition and duration parameters given aggregate counts from a specific location, thus adapting the model to a region or individual hospital site of interest. Samples from this posterior can then be used to produce future forecasts of any counts of interest. Using data from the United States and the United Kingdom, we show our mechanistic approach provides competitive probabilistic forecasts for the future even as the dynamics of the pandemic shift. Furthermore, we show how our model provides insight about recovery probabilities or length of stay distributions, and we suggest its potential to answer challenging what-if questions about the societal value of possible interventions.
This study explored the association between the five key air pollutants (Nitrogen Dioxide (NO2), Sulphur Dioxide (SO2), Particulate Matter (PM2.5, PM10), and Carbon Monoxide (CO)) and COVID-19 incidences in India. The COVID-19 confirmed cases, air pollution concentration and meteorological variables (temperature, wind speed, surface pressure) for district and city scale were obtained for 2019 and 2020. The location-based air pollution observations were converted to a raster surface using interpolation. The deaths and positive cases are reported so far were found highest in Mumbai (436 and 11394), followed by Ahmedabad (321 and 4991), Pune (129 and 2129), Kolkata (99 and 783), Indore (83 and 1699), Jaipur (53 and 1111), Ujjain (42 and 201), Surat (37 and 799), Vadodara (31 and 400), Chennai (23 and 2647), Bhopal (22 and 652), Thane (21 and 1889), respectively. Unlike the other studies, this study has not found any substantial association between air pollution and COVID-19 incidences at the district level. Considering the number of confirmed cases, the coefficient of determination (R2) values estimated as 0.003 for PM2.5, 0.002 for PM10 and SO2, 0.001 for CO, and 0.0002 for NO2, respectively. This suggests an absolute no significant association between air pollution and COVID-19 incidences (both confirmed cases and death) in India. The same association was observed for the number of deaths as well. For COVID-19 confirmed cases, none of the five pollutants has exhibited any statistically significant association. Additionally, except the wind speed, the climate variables have no produced any statistically significant association with the COVID-19 incidences.